Demand forecast for plasma collections

Exploring the factors shaping future demand for plasma-derived therapies

Plasma-derived therapies provide essential treatment options across a broad range of immunologic, hematologic, and other serious medical conditions. As global demand continues to grow, understanding the factors influencing plasma utilization has become increasingly important for manufacturers, healthcare stakeholders, and the broader plasma industry.

In this peer-reviewed publication, Acumetis expert Maik Klasen, PhD, GM, Senior Partner and Insights and Analytics Practice Lead, and Jason Brunton, PhD, Principal, examine the evolving dynamics shaping demand for plasma-derived products, with a particular focus on immunoglobulins (Ig)—the primary driver of global plasma demand—alongside albumin and coagulation factors. The publication explores how therapeutic innovation, evolving treatment patterns, competitive therapies, and regional market differences are influencing future plasma patient requirements.

Read the full peer-reviewed publication  →   Demand forecast for plasma collections

Why demand forecasting matters

Forecasting future plasma demand requires understanding the clinical, therapeutic, and market factors influencing the use of plasma-derived therapies as treatment landscapes continue to evolve. As treatment patterns evolve and new therapeutic options become available, demand continues to shift across product categories and global markets.

Understanding these evolving trends provides important context for anticipating future plasma collection requirements and the changing needs of patients who rely on plasma-derived therapies.

Looking beyond demand growth

While overall demand for plasma-derived therapies continues to increase, the factors influencing growth differ across product categories. Immunoglobulins (Ig) remain the primary driver of global plasma demand, while albumin and coagulation products are shaped by distinct clinical applications, regional utilization patterns, and competitive treatment landscapes. Together, these trends provide important context for understanding the future outlook for plasma patients.

About the publication

Demand Forecast for Plasma Collections provides an evidence-based overview of the trends influencing the global plasma-derived product market. The publication examines demand across immunoglobulins (Ig), albumin, and coagulation factors while exploring the impact of therapeutic innovation, competitive mechanisms of action, and regional utilization patterns on future plasma patients.

Drawing on published literature alongside proprietary Acumetis EMR-derived data, the publication provides a comprehensive perspective on the evolving plasma landscape and the factors expected to shape long-term demand.

Read the full publication in Annals of Blood:

Insights & Analytics

Rare and specialty markets require granular insight and expert interpretation to uncover the hidden insights that others can’t see. Our proprietary information platforms deliver patient-level granularity across rare and specialty indications creating transparency in markets that are otherwise opaque. But data alone doesn’t drive strategy.

Our senior experts translate those signals into clear, defensible recommendations that sharpen decisions across medical, access, and commercial teams. The result: a clearer picture of what’s happening in your market, smarter prioritization of where to act, and decisions your team can stand behind.

Connect with our Insights & Analytics team  →   Learn about our team